arrow
J

Jonathan D. Schertzer

farncombe family digestive health research institute
H指数:58
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Statins promote muscle metabolic danger and NLRP3-mediated myopathy via lower protein-prenylation and YAP

他汀类药物通过降低蛋白质前酯化和YAP促进肌肉代谢性危险及NLRP3介导的肌病

2026-06-190
OA
Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice

方, H.; 安赫, F.F.; 扎达, D.K.; 巴拉, N.G.; E-Lacerda, R.R.; McAlpin, B.T.; 怀利, R.; 贝尔蒂奥姆, L.; 奥德特-沃尔什, E.; O’Dwyer, C.; 等. 肠道微生物菌群中D-乳酸底物陷阱可改善肥胖小鼠的血糖和脂肪肝疾病。Cell Metab. 2025, 37, 1–4. [Google Scholar] [CrossRef] [PubMed]

2025-07-290
OAAI
GDF15 links adipose tissue lipolysis with anxiety

GDF15将脂肪组织脂解与焦虑联系起来

2025-04-151
OA
Wearable Aptalyzer Integrates Microneedle and Electrochemical Sensing for In Vivo Monitoring of Glucose and Lactate in Live Animals

可穿戴Aptalyzer集成了微针和电化学传感,用于活体动物体内监测葡萄糖和乳酸

2024-06-1711
PRE
High-fructose feeding suppresses cold-stimulated brown adipose tissue glucose uptake independently of changes in thermogenesis and the gut microbiome
2022-09-0120
OAAI
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome
2022-07-0135
OAAI